New Brunswick Scientific (www.nbsc.com) has incorporated Allen Bradley PLC controls into its BioFlo Pro fermentors and bioreactors for system regulation, as well as easy exchange of data with auxiliary bioprocessing systems.
New Brunswick Scientific (www.nbsc.com) has incorporated Allen Bradley PLC controls into its BioFlo Pro fermentors and bioreactors for system regulation, as well as easy exchange of data with auxiliary bioprocessing systems. The 75–3,000 L BioFlo Pro fermentors and bioreactors for R&D through GMP production use modular components for rapid delivery and ready customization at any time. Integration of Allen Bradley Control Logix Process Controller provides a variety of benefits ranging from rapid response for system control, to the ability to transmit both an alarm signal, as well as details of the alarm condition to manufacturing supervisory systems. NBS BioFlo Pro fermentors and bioreactors feature a small footprint to minimize space requirements and open piping frame with plenty of space between valves for easy access during operation and maintenance.
Mastering Antibody-Drug Conjugates
December 19th 2024In this episode, we explore BIOVECTRA’s capabilities in antibody-drug conjugate (ADC) manufacturing, from complex conjugation chemistry to synthesis of highly potent payloads. We’ll also showcase how BIOVECTRA’s extensive experience in complex chemistries and specialized small molecule manufacturing gives them a unique perspective, strengthening their approach to ADC production and ensuring clients receive custom solutions across all project stages.
Drug Shortages and Complying with FDA’s 21 CFR 211.110 Guidance
April 2nd 2025Susan J. Schniepp, distinguished fellow at Regulatory Compliance Associates, and Rona LeBlanc-Rivera, PhD, principal consultant, Regulatory Affairs at Regulatory Compliance Associates, answer some questions about FDA’s January 2025 21 CFR 211.110 guidance document.